PFIZER REPORTS FIRST-QUARTER 2017 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pfizer (PFE) Tops Q1 EPS by 2c, Offers FY Guidance
May 2, 2017 6:47 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.69, $0.02 better than the analyst estimate of $0.67. Revenue for the quarter came in at $12.8 billion versus the consensus estimate of $13.09 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.55. Pfizer sees... More
